100% Quality Guarantee
PhD-Level Technical Support
Key Features

Praluzatamab Biosimilar (CD166) Antibody (HDBS0154)

SKU HDBS0154
Antibody Type Biosimilar Reference Antibody
Applications IHC
Applications FC
Applications Drug Development
Applications Pharmacokinetics
Disease Area Cancer
Protein CD166
Reactivity Human
Host Species Humanized
Isotype IgG1
€431

Request a formal quotation

A PDF quote with its own quote number, ready for your purchasing office to raise a PO against. Back within 4 working hours, from a PhD scientist — not an autoresponder.

  • PO-ready PDFQuote number, VAT, Incoterms
  • Volume pricing appliedDiscounts from 2 kits up
  • Valid 30 daysPrices held while you get sign-off
Anything we should know? optional

No account needed. We use your details only to prepare and send this quote. If it's urgent, say so in the box and we'll come back the same working day.

Global Shipping: 80+ Countries
White Glove Service: Available upon request
Batch Consistency: Contact Sales
Distributors: 60+ Countries

Description

system_update_altDatasheet

Praluzatamab Biosimilar (CD166) Antibody (HDBS0154)

Praluzatamab Biosimilar CD166 Antibody (DATK166)The Praluzatamab Biosimilar CD166 Antibody (DATK166) is a cutting-edge tool for researchers interested in studying CD166, a cell surface protein involved in cell adhesion and signaling processes. This monoclonal antibody, developed through advanced biosimilar technologies, is highly specific and sensitive for detecting CD166 in human samples. It has been rigorously validated for use in various applications, including immunohistochemistry and flow cytometry.CD166, also known as activated leukocyte cell adhesion molecule (ALCAM), plays a crucial role in cell migration, proliferation, and differentiation, making it a key player in cancer progression and metastasis.

Targeting CD166 with Praluzatamab can provide insights into the biology of tumors expressing this protein, aiding in the development of novel therapeutic strategies for cancer treatment.By offering a high level of specificity and sensitivity, the Praluzatamab Biosimilar Anti-CD166 Antibody (DATK166) is an invaluable tool for researchers studying cancer biology, tumor immunology, and drug development. Its ability to accurately detect and analyze CD166 expression in various cell types makes it a versatile and reliable choice for advancing scientific discoveries in the field of oncology.

View AllClose

0 Reviews

0
Based on 0 reviews

No reviews yet. Be the first to share your experience!

View AllClose